Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Hansi Flick makes a decision that could change the future of the Barcelona star

Barcelona manager Hansi Flick has struggled to find solutions to his recent slump in results in La Liga, and that has gone hand in hand with a lack of contributions from players returning from injury. Among them, no case is more followed than that of Frenkie de Jong.

The Dutchman has not found his best form since returning to the field in October after five months out. Flick has been his number one defender so far and believes De Jong in his prime fits perfectly into his plans for the team. However, Sport says his opinion has changed in recent months and, having seen De Jong in action, he too has his doubts.

The German manager is now open to selling De Jong next summer in favor of a more physical and positional midfielder, someone who can compete with Marc Casado as the deepest midfielder in his formation. There are also doubts about whether de Jong will want to stay if he is not going to have a starting role.

De Jong’s contractual situation is a headache for Barcelona, ​​​​which sees no signs of renewal on the horizon. His contract ends in the summer of 2026 and the Blaugrana are reportedly willing to accept as little as €20m for him, but there is a feeling within the Catalan club that his contract could expire.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.